06 May 2025
06 May 2025
Zimmer Biomet expects that the majority of tariff impact on profits will be incurred in the second half of the year.
The terms of the purchase agreement include a $6m transaction, split evenly between cash and Firefly common stock priced at $3.50 per share.
The Aurora system’s 40mm detector is stated to provide double the coverage of other hybrid systems' CT detectors.
The REGENT-1 Australia study found significant improvements in insulin sensitivity and beta cell function after 12 weeks, which persisted at 48 weeks.
The investigational device exemption trial enrolled 130 acute intermediate-risk pulmonary embolism patients across 22 US sites.
NeuroMetrix’s Quell platform is a cloud-enabled wearable neuromodulation solution intended to treat fibromyalgia symptoms.
The FDA designation is a step forward for Neuralink as owner Elon Musk faces increasing scrutiny.
OcuSciences’ OcuMet Beacon measures FPF, which may aid in the early detection of glaucoma.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
